European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication

被引:430
作者
von Karsa, L. [1 ]
Patnick, J. [2 ,3 ]
Segnan, N. [4 ]
Atkin, W. [5 ]
Halloran, S. [6 ,7 ]
Lansdorp-Vogelaar, I. [8 ]
Malila, N. [9 ]
Minozzi, S. [4 ]
Moss, S. [10 ]
Quirke, P. [11 ]
Steele, R. J. [12 ]
Vieth, M. [13 ]
Aabakken, L. [14 ]
Altenhofen, L. [15 ]
Ancelle-Park, R. [16 ]
Antoljak, N. [17 ,18 ]
Anttila, A. [9 ]
Armaroli, P. [4 ]
Arrossi, S. [19 ]
Austoker, J.
Banzi, R. [20 ]
Bellisario, C. [4 ]
Blom, J. [21 ]
Brenner, H. [22 ]
Bretthauer, M. [23 ]
Cancela, M. Camargo [24 ,25 ]
Costamagna, G. [26 ]
Cuzick, J. [27 ]
Dai, M. [28 ]
Daniel, J. [25 ,29 ]
Dekker, E. [30 ]
Delicata, N. [31 ]
Ducarroz, S.
Erfkamp, H. [32 ]
Espinas, J. A. [33 ]
Faivre, J. [34 ,51 ]
Wood, L. Faulds [35 ]
Flugelman, A. [36 ]
Frkovic-Grazio, S. [37 ]
Geller, B. [38 ]
Giordano, L. [4 ]
Grazzini, G. [39 ]
Green, J.
Hamashima, C. [40 ]
Herrmann, C. [25 ,41 ]
Hewitson, P.
Hoff, G. [42 ,43 ]
Holten, I. [44 ]
Jover, R. [45 ]
Kaminski, M. F. [46 ,47 ]
机构
[1] Int Agcy Res Canc, Qual Assurance Grp, Early Detect & Prevent Sect, F-69372 Lyon 08, France
[2] NHS Canc Screening Programmes Sheffield, Sheffield, S Yorkshire, England
[3] Univ Oxford, Canc Screening Res Unit, Canc Epidemiol Unit, Oxford, England
[4] AO Citta Salute & Sci Torino, CPO Piemonte, Turin, Italy
[5] Univ London Imperial Coll Sci Technol & Med, London, England
[6] Royal Surrey Cty Hosp NHS Fdn Trust, Bowel Canc Screening So Programme Hub, Guildford, Surrey, England
[7] Univ Surrey, Guildford GU2 5XH, Surrey, England
[8] Erasmus MC, Rotterdam, Netherlands
[9] Finnish Canc Registry, FIN-00170 Helsinki, Finland
[10] Royal Canc Hosp, Inst Canc Res, Sutton, Surrey, England
[11] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England
[12] Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland
[13] Klinikum Bayreuth, Inst Pathol, Bayreuth, Germany
[14] Stavanger Univ Hosp, Dept Med Gastroenterol, Stavanger, Norway
[15] Cent Res Inst Ambulatory Hlth Care, Berlin, Germany
[16] Direct Gen Sante, Paris, France
[17] Croatian Natl Inst Publ Hlth, Zagreb, Croatia
[18] Univ Zagreb, Sch Med, Zagreb 41001, Croatia
[19] Consejo Nacl Invest Cient & Tecn, CEDES, RA-1033 Buenos Aires, DF, Argentina
[20] Mario Negri Inst Pharmacol Res, Milan, Italy
[21] Karolinska Inst, Stockholm, Sweden
[22] German Canc Res Ctr, D-6900 Heidelberg, Germany
[23] Univ Oslo, Inst Hlth & Soc, Oslo, Norway
[24] Natl Canc Registry, Cork, Ireland
[25] Int Agcy Res Canc, F-69372 Lyon, France
[26] A Gemelli Univ Hosp, Rome, Italy
[27] Queen Mary Univ London, Wolfson Inst Prevent Med, London, England
[28] Chinese Acad Med Sci, Canc Inst & Hosp, Beijing 100730, Peoples R China
[29] Amer Canc Soc, Atlanta, GA 30329 USA
[30] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[31] Minist Hlth Elderly & Community Care, Natl Hlth Screening Serv, Valletta, Malta
[32] Univ Appl Sci FH Joanneum, Graz, Austria
[33] Catalan Canc Strategy, Lhospitalet De Llobregat, Spain
[34] Univ Dijon, Digest Canc Registry Burgundy, INSERM, U866, F-21004 Dijon, France
[35] Lynns Bowel Canc Campaign, Twickenham, England
[36] Natl Israeli Breast & Colorectal Canc Detect, Haifa, Israel
[37] Univ Med Ctr Ljubljana, Dept Gynecol Pathol & Cytol, Ljubljana, Slovenia
[38] Univ Vermont, Burlington, VT USA
[39] Canc Prevent & Res Inst ISPO, Florence, Italy
[40] Natl Canc Ctr, Tokyo 104, Japan
[41] Canc League Eastern Switzerland, St Gallen, Switzerland
[42] Canc Registry Norway, Oslo, Norway
[43] Telemark Hosp, Skien, Norway
[44] Danish Canc Soc, Copenhagen, Denmark
[45] Hosp Gen Univ Alicante, Alicante, Spain
[46] Maria Sklodowska Curie Mem Canc Ctr, Warsaw, Poland
[47] Med Ctr Postgrad Educ, Warsaw, Poland
[48] Lithuanian Canc Registry, Vilnius, Lithuania
[49] CHU Caen, INSERM, U1086, UCBN, Caen, France
[50] Catholic Univ Korea, Coll Med, Seoul, South Korea
关键词
CLINICAL-PRACTICE GUIDELINES; RANDOMIZED CONTROLLED-TRIAL; AMERICAN-COLLEGE; EDITION; COLONOSCOPY; SURVEILLANCE; PREVALENCE; NEOPLASMS; SOCIETY; POLYPS;
D O I
10.1055/s-0032-1325997
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Population-based screening for early detection and treatment of colorectal cancer (CRC) and precursor lesions, using evidence-based methods, can be effective in populations with a significant burden of the disease provided the services are of high quality. Multidisciplinary, evidence-based guidelines for quality assurance in CRC screening and diagnosis have been developed by experts in a project co-financed by the European Union. The 450-page guidelines were published in book format by the European Commission in 2010. They include 10 chapters and over 250 recommendations, individually graded according to the strength of the recommendation and the supporting evidence. Adoption of the recommendations can improve and maintain the quality and effectiveness of an entire screening process, including identification and invitation of the target population, diagnosis and management of the disease and appropriate surveillance in people with detected lesions. To make the principles, recommendations and standards in the guidelines known to a wider professional and scientific community and to facilitate their use in the scientific literature, the original content is presented in journal format in an open-access Supplement of Endoscopy. The editors have prepared the present overview to inform readers of the comprehensive scope and content of the guidelines.
引用
收藏
页码:51 / 59
页数:9
相关论文
共 71 条
  • [1] [Anonymous], COL CANC SCREEN SURV
  • [2] [Anonymous], EUR UN BOW CANC SCRE
  • [3] [Anonymous], 1968, PUBLIC HLTH PAP, DOI DOI 10.1001/ARCHINTE.1969.00300130131020
  • [4] [Anonymous], COLORECTAL CANC SCRE
  • [5] [Anonymous], BOW SCREEN PROGR CLI
  • [6] [Anonymous], EUROPEAN GUIDELINES
  • [7] [Anonymous], DAT 2002
  • [8] [Anonymous], CANC CONTROL
  • [9] [Anonymous], GUID MAN COL CANC
  • [10] [Anonymous], 2003, OFF J EUR UNION